Firm Matters
BackKhaitan & Co advised Torrent Pharmaceuticals Ltd on its proposed acquisition of a stake in J.B. Pharma from KKR, valuing J.B. Pharma at INR 25,689 crores. The deal includes acquisition of KKR’s 46.39% stake in J.B. Pharma for INR 11,917 crores, an open offer for acquisition of up to 26% stake of J.B. Pharma, a potential 2.80% stake purchase from certain employees and a proposed merger of J.B. Pharma with Torrent.
Deal Team
The core team included Bhavik Narsana (Partner), Mehul Shah (Partner), Arindam Ghosh (Partner), Gaurav Malhotra (Counsel), Shashank Patil (Counsel), Rushabh Gala (Principal Associate), Shweta Dwivedi (Consultant), Shubhra Wadhawan (Consultant), Pragya Mishra (Associate) and Kashvi Shetty (Associate) with strategic guidance from Haigreve Khaitan (Senior Partner).
The deal was assisted by:
Banking and Finance: Kumar Saurabh Singh (Partner) and Rahul Chakraborti (Partner)
Competition / Antitrust: Anshuman Sakle (Partner)
Direct Tax: Vinita Krishnan (Executive Director) and Rahul Jain (Partner), Shabnam Shaikh (Partner)
Dispute Resolution: Kingshuk Banerjee (Partner)
Employment, Labour and Benefits: Deepak Kumar (Partner)
Intellectual Property: Nishad Nadkarni (Partner)
Real Estate: Amit H Wadhwani (Partner)
